Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cotton

Showing results (181-190 of 219) with videos related to

Pageof 22
Sort By:
Chest|December 18, 2001
Methacholine challenge: test-shortening proceduresD W Cockcroft, D D Marciniuk, T S Hurst, et al.
Chest|November 18, 2000
Routine pulse oximetry during methacholine challenges is unnecessary for safetyD W Cockcroft, T S Hurst, D D Marciniuk, et al.
Canadian Respiratory Journal|April 28, 2007
An empirical continuous positive airway pressure trial for suspected obstructive sleep apneaRobert P Skomro, David J Cotton, John A Gjevre, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 1999
RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sitesV Dive, J Cotton, A Yiotakis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 3, 2000
Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 TeamJ S Currier, C Spino, J Grimes, et al.
Biochemical and Biophysical Research Communications|August 24, 1995
Chemical synthesis, structural and functional characterisation of noxiustoxin, a powerful blocker of lymphocyte voltage-dependent K+ channelsE Drakopoulou, J Cotton, H Virelizier, et al.
European Journal of Biochemistry|February 15, 1997
A potassium-channel toxin from the sea anemone Bunodosoma granulifera, an inhibitor for Kv1 channels. Revision of the amino acid sequence, disulfide-bridge assignment, chemical synthesis, and biological activityJ Cotton, M Crest, F Bouet, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 25, 2000
Parathyroid hormone-related peptide stimulates proliferation of highly tumorigenic human SV40-immortalized breast epithelial cellsC Cataisson, M Lieberherr, M Cros, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysisC Junot, M F Gonzales, E Ezan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 4, 1999
A functional, discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1alpha chemokine bindingS E Howie, M L Fernandes, I Heslop, et al.
Pageof 22

Showing results (181-190 of 219) with videos related to

Sort By:
Pageof 22
Chest|December 18, 2001
Methacholine challenge: test-shortening proceduresD W Cockcroft, D D Marciniuk, T S Hurst, et al.
Chest|November 18, 2000
Routine pulse oximetry during methacholine challenges is unnecessary for safetyD W Cockcroft, T S Hurst, D D Marciniuk, et al.
Canadian Respiratory Journal|April 28, 2007
An empirical continuous positive airway pressure trial for suspected obstructive sleep apneaRobert P Skomro, David J Cotton, John A Gjevre, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 1999
RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sitesV Dive, J Cotton, A Yiotakis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 3, 2000
Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 TeamJ S Currier, C Spino, J Grimes, et al.
Biochemical and Biophysical Research Communications|August 24, 1995
Chemical synthesis, structural and functional characterisation of noxiustoxin, a powerful blocker of lymphocyte voltage-dependent K+ channelsE Drakopoulou, J Cotton, H Virelizier, et al.
European Journal of Biochemistry|February 15, 1997
A potassium-channel toxin from the sea anemone Bunodosoma granulifera, an inhibitor for Kv1 channels. Revision of the amino acid sequence, disulfide-bridge assignment, chemical synthesis, and biological activityJ Cotton, M Crest, F Bouet, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 25, 2000
Parathyroid hormone-related peptide stimulates proliferation of highly tumorigenic human SV40-immortalized breast epithelial cellsC Cataisson, M Lieberherr, M Cros, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysisC Junot, M F Gonzales, E Ezan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 4, 1999
A functional, discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1alpha chemokine bindingS E Howie, M L Fernandes, I Heslop, et al.
Pageof 22